Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel decarboxylation condensation and asymmetric reduction method enhances purity and reduces costs for sitagliptin manufacturing supply chains.
Novel visible-light copper catalyzed synthesis for high-purity alkynyl phosphate intermediates. Offers mild conditions and scalable production for pharmaceutical supply chains.
Patent CN113461555A introduces a streamlined Suzuki route for Terbutaline, eliminating hazardous hydrogenation and reducing steps for cost-effective API manufacturing.
Patent CN114394939A reveals a green 3-step route for cimetidine with >90% yield. Discover cost reduction in pharmaceutical manufacturing and high-purity supply solutions.
Patent CN110483571B reveals novel bulky electron-deficient ligands enhancing Pd-catalyzed coupling yields significantly while ensuring air stability for reliable supply chains.
Patent CN120098034A reveals a neutral photocatalytic route for 1,2-bisphosphonoethane compounds, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105601630A reveals high-yield Vilsmeier route for diazepine intermediates. Achieve cost reduction and supply chain reliability with scalable manufacturing.
Novel biphenanthrene skeleton catalyst offers high enantioselectivity for spiroketal manufacturing, ensuring supply chain stability and cost efficiency.
Novel synthesis of (R)-4-propyl dihydrofuran-2-one via Meldrum's acid. High optical purity, scalable route for Brivaracetam intermediates. Cost-effective manufacturing solution.
Patent CN110590525A reveals scalable manganese-catalyzed route reducing costs and enhancing supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102040636A details a novel beta-arbutin synthesis route utilizing alpha-glucose pentaacetate byproducts for significant cost reduction and supply chain stability.
Advanced preparation method of Ivermectin utilizing Avermectin B2. Enhances yield to 72% while eliminating toxic tributyltin reagents for cost-effective manufacturing.
Patent CN113683650B reveals efficient synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel pimelic acid route offers 97% purity and 85% yield. Reduces cost and environmental impact for pharmaceutical supply chains significantly.
Novel copper-catalyzed one-pot synthesis offers high yield and purity for complex heterocycles, ensuring cost-effective supply chain solutions.
Patent CN111302971B details continuous 5-cyanodiol synthesis offering high purity and yield. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN103193858B details a convergent synthesis for spirostanol glycoalkaloids, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN104447696B details improved Lansoprazole synthesis yielding 98% purity. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN119118766B reveals hydrophilic carbon catalyst for deuterated intermediates. Enables cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover the novel preparation method for 1,2,3,6-tetrahydrophthalimide via patent CN110642774A. Achieve higher purity and cost reduction in pharmaceutical intermediates manufacturing.